GP

Gustavo Pesquin

Chief Executive Officer

Asklepios BioPharmaceutical, Inc. - (AskBio)

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Asklepios BioPharmaceutical, Inc. - (AskBio)
Industry
research
Employees
510.0
Seniority
C suite
Annual Revenue
9000000.0
Total Funding
252850854.0
Latest Funding
Other

Professional Summary

Gustavo Pesquin serves as Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio). Asklepios BioPharmaceutical, Inc. - (AskBio) operates in the research sector with approximately 510.0 employees. The company is headquartered in New York, New York. Asklepios BioPharmaceutical, Inc. - (AskBio) generates annual revenue of 9000000.0. To date, Asklepios BioPharmaceutical, Inc. - (AskBio) has raised 252850854.0 in total funding, with the most recent round being Other.

Industry & Role Insights

  • • MessageCEO tracks 2,961 executives in the research sector.
  • • 6,951 executive contacts are available in New York.
  • • Our database includes 201,464 c suite-level executives.

Technologies

Outlook GoDaddy Hosting Amazon AWS Mobile Friendly Google Analytics WordPress.org Google Font API Workday Recruit Google Tag Manager Nginx YouTube Remote

Keywords

aav adenoassociated virus gene therapy rare disease aav manufacturing molecular medicine nucleic acid epigenome doggybone dna biotechnology research aav technology clinical trials genetic diseases therapeutic pipeline orphan drug designation patient advocacy fda approvals muscular dystrophy neuromuscular disorders cns disorders pompe disease parkinson's disease metabolic diseases cardiovascular diseases investigational treatments rare diseases gene therapy clinical development patient-centered approach biomanufacturing capsid library synthetic promoters research collaborations genetic medicine neurodegenerative diseases adnoviruses monogenic disorders leadership team biotherapy therapeutic gene delivery genome editing disease-modifying therapies pharmaceutical partners patient care clinical development research & development technology platform genetic breakthroughs genetic predisposition innovative therapeutics healthcare innovation life sciences biopharmaceuticals market authorization vaccine technology scientific expertise clinical outcomes biotech industry personalized medicine adeno-associated virus clinical-stage genetic disorders neuromuscular diseases central nervous system huntington's disease limb-girdle muscular dystrophy innovative science transformative therapeutics proprietary technology pro10 cell line gene therapy pipeline regulatory designations collaborations bayer ag subsidiary patient-centric advanced therapies transformative molecular medicines therapeutic advancements biotechnology patient demographics unmet medical needs health care health wellness & fitness hospital & health care

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Gustavo Pesquin in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Asklepios BioPharmaceutical, Inc. - (AskBio).

Gustavo Pesquin's Position in the MessageCEO Database

  • •Gustavo Pesquin is 1 of 1 verified executive contact we track at Asklepios BioPharmaceutical, Inc. - (AskBio).
  • •2,871 verified executive contacts in research are in the MessageCEO database.
  • •6,777 verified executive contacts in New York are in the database.
  • •7 verified contacts work at research companies in the 510.0 employee range (same size as Asklepios BioPharmaceutical, Inc. - (AskBio)).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

Frequently Asked Questions

How do I reach Gustavo Pesquin directly?

Gustavo Pesquin's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio). Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Gustavo Pesquin work for?

Gustavo Pesquin is Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio), a company in the research sector with 510.0 employees. The company is based in New York, New York.

Can I pitch or sell to Gustavo Pesquin?

As Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio), Gustavo Pesquin is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Gustavo Pesquin directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Gustavo Pesquin in?

Gustavo Pesquin works in the research industry as Chief Executive Officer at Asklepios BioPharmaceutical, Inc. - (AskBio). MessageCEO provides verified contact information for executives across all major industries.

Is Gustavo Pesquin's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gustavo Pesquin's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: November 8, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans